Blood Pressure Management in Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
Overview
Affiliations
The relationship between presenting blood pressure in acute ischemic stroke patients and outcome is complex. Several studies have demonstrated a U-shaped curve with worse outcomes when blood pressure is high or low. The American Heart Association/American Stroke Association guidelines recommend values of blood pressure < 185/110 mmHg in patients treated with intravenous t-PA and "permissive hypertension" up to 220/120 mmHg in those not treated with intravenous t-PA. The optimal blood pressure target is less clear in patients undergoing mechanical thrombectomy. Before thrombectomy, the guidelines recommend a blood pressure < 185/110 mmHg though patients with even lower systolic blood pressures may have better outcomes. During and after thrombectomy, the guidelines recommend a blood pressure < 180/105 mmHg. However, several studies have suggested that during thrombectomy the primary goal should be to prevent significant low blood pressure (e.g., target systolic blood pressure > 140 mmHg or MAP > 70 mmHg). After thrombectomy, the primary goal should be to prevent high blood pressure (e.g., target systolic blood pressure < 160 mmHg or MAP < 90 mmHg). To make more specific recommendations, large, randomized-control studies are needed that address factors such as the baseline blood pressure, timing and degree of revascularization, status of collaterals, and estimated risk of reperfusion injury.
Blood pressure management in reperfused ischemic stroke.
Varela L, Diaz Menai S, Escobar Liquitay C, Burgos M, Ivaldi D, Garegnani L Cochrane Database Syst Rev. 2025; 3:CD016085.
PMID: 40035316 PMC: 11877636. DOI: 10.1002/14651858.CD016085.
Individualized autoregulation-guided arterial blood pressure management in neurocritical care.
Gomez J, Bhende B, Mathur R, Gonzalez L, Shah V Neurotherapeutics. 2025; 22(1):e00526.
PMID: 39828496 PMC: 11840358. DOI: 10.1016/j.neurot.2025.e00526.
Fu L, Zhou R, Jiang W, Lan L, Chen X, Cao Y Vasc Health Risk Manag. 2024; 20:533-539.
PMID: 39651401 PMC: 11625192. DOI: 10.2147/VHRM.S486834.
Chen M, Sauer L, Herwig M, Jesser J, Kieser M, Potreck A Neurol Res Pract. 2024; 6(1):46.
PMID: 39354580 PMC: 11443703. DOI: 10.1186/s42466-024-00345-0.
Wiacek M, Tomaszewska-Lampart I, Dziedzic M, Kaczorowska A, Bartosik-Psujek H J Clin Med. 2024; 13(13).
PMID: 38999273 PMC: 11242044. DOI: 10.3390/jcm13133707.